• Drug Approval of Interest: Abilify MyCite

    FDA approved Monday a drug with a digital ingestion tracking system. The product, aripiprazole tablets with sensor (Abilify MyCite—Otsuka Pharmaceutical, Proteus Digital Health), features an ingestible sensor embedded in the drug that records that the medication was taken. "Being able to track ingestion of medications prescribed for mental illness may be useful for some patients," noted Mitchell Mathis, MD, director of the Division of Psychiatry Products in FDA's Center for Drug Evaluation and Research.